Phio Pharmaceuticals
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
11 Apex Dr Ste 300A, Marlborough, Massac...Phone Number
(508) 767-3861Website
www.phiopharma.comRevenue
-Stock Symbol
PHIOIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Phio Pharmaceuticals
Phio Pharmaceuticals Inc. is a US biotechnology company focused on the field of siRNA. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phios Pharmaceuticals in 2018. The company is using its siRNA platform to develop a pipeline of dermatology and ophthalmology therapeutics.Explore more
Phio Pharmaceuticals Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Phio Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Phio Pharmaceuticals recently announced quarterly report
Funding: Get notified immidiatlly once Phio Pharmaceuticals has new funding data
Click to see if Phio Pharmaceuticals had a recent Job posting/layoffs
Product Launch: Get notified when Phio Pharmaceuticals launches new products
Check if Phio Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Check out if Phio Pharmaceuticals is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Phio Pharmaceuticals
Phio Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Phio Pharmaceuticals
Compare insights from companies similar to Phio Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Phio Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Phio Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Phio Pharmaceuticals.
Phio Pharmaceuticals financials insights
Gather financial insights about Phio Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Stock Offering
$10.4M
2020
Debt
$150K
2021
Share Placement
$14M
Phio Pharmaceuticals Tech Stack
A closer look at the technologies used by Phio Pharmaceuticals
Most Recent Scoops
Project
reported an 85% response rate in the highest dose cohort of its Phase 1B trial for PH762, with 60% to 70% of patients in that cohort achieving total clearance, and an overall response rate of 65% across all cohorts.
Medical Research, Clinical Operations
Project
Phio Pharmaceuticals is developing the next clinical trial design for PH762, with an FDA submission planned for early next quarter and a Phase 2 trial expected to commence in Q1 of next year.
Clinical Operations
Project
Phio Pharmaceuticals has reported a clean toxicology profile in non-human primate studies for PH894, which features a dual mode of action directly killing tumor cells and activating immune cells while remaining precisely selective for the BRD4 gene, avoiding toxicities associated with prior non-selective BRD4 programs.
Medical Research, Pharmaceuticals
Project
completed its Phase 1B trial for PH762 in January of the current year, enrolling 22 patients across five dose-escalating cohorts including 20 CSCC, one Merkel cell, and one melanoma patient with all enrolled patients completing the trial and endpoints covering safety and tolerability, tumor pathology, and pharmacokinetics.
Medical Research, Clinical Operations
Project
Research & Development
Phio Pharmaceuticals News & Media
Phio Pharmaceuticals Announces Participation in the Life Sciences Investor Forum on June 24-25, 2026
The Company invites investors, advisors, and analysts interested in Phio Pharmaceuticals to attend the live presentation and one-on-one meetings. Phio Pharmaceuticals Corp. (NASDAQ:PHIO) KING OF PRUSSIA, PA, UNITED STATES, June 23, 2026 /EINPresswire. …Phio Pharmaceuticals to Participate in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
Live Presentation and Q&A: Thursday, May 28, 2026, 12 PM EDT Phio Pharmaceuticals Corp. (NASDAQ:PHIO) KING OF PRUSSIA, PA, UNITED STATES, May 26, 2026 /EINPresswire.com/ -- Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA …Pyramid Pharma Services Announces Drug Product Manufacturing Agreement for Phio Pharmaceuticals’ Lead Oncology Candidate
Advancing U.S.-based cGMP manufacturing to support clinical and future commercial objectives of a novel siRNA therapy for skin cancers COSTA MESA, CA, UNITED STATES, April 8, 2026 /EINPresswire.com/ -- Pyramid Pharma Services, a U.S.-based contract …Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762
A Critical Next Step in Advancing Phio’s PH-762 Program to Treat Cutaneous Carcinomas Phio Pharmaceuticals Corp. (NASDAQ:PHIO) KING OF PRUSSIA, PA, UNITED STATES, April 1, 2026 /EINPresswire.com/ -- Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a …
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Phio Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Phio Pharmaceuticals Inc. is a US biotechnology company focused on the field of siRNA. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phios Pharmaceuticals in 2018. The company is using its siRNA platform to develop a pipeline of dermatology and ophthalmology therapeutics.... Read More
